Atlas Trials

Effect of Montelukast Therapy on Clinical Course, Pulmonary Function, and Mortality in Patients With COVID-19

Clinical trial NCT05094596 · UNKNOWN

Trial details

NCT number
NCT05094596
Sponsor
Bugra Kerget
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19 Pneumonia
Start date
2021-10-22
Primary completion
2021-12-22
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.